Investor profile
Pontifax Funds has backed 11 European tech companies across 11 funding rounds between 2016 and 2023, joining rounds totalling €518M. Most active in Healthtech. Data as of 6 Aug 2026.
Also recorded as: Pontifax · Pontifax Venture Capital
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Amolyt Pharma | France | 1 | €129M |
| Anaveon | Switzerland | 1 | €105M |
| Emergence Therapeutics | Germany | 1 | €87M |
| Precirix | Belgium | 1 | €80M |
| V-Wave | Israel |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Amolyt Pharma | Series C | €129M | 2023-01 |
| Anaveon | Series B | €105M | 2021-12 |
| Emergence Therapeutics | Other | €87M | 2021-12 |
| Precirix |
| 1 |
| €56M |
| raziel therapeutics | Israel | 1 | €20M |
| Metabomed | Israel | 1 | €16M |
| Eyevensys | France | 1 | €9.0M |
| EyeYon Medical | Israel | 1 | €6.5M |
| TargEDys | France | 1 | €5.8M |
| Sweetch | Israel | 1 | €3.1M |
| Series B |
| €80M |
| 2022-03 |
| V-Wave | Other | €56M | 2018-02 |
| raziel therapeutics | Series C | €20M | 2019-10 |
| Metabomed | Series A | €16M | 2016-04 |
| Eyevensys | Series A | €9.0M | 2016-09 |
| EyeYon Medical | Series B | €6.5M | 2017-03 |
| TargEDys | Series A | €5.8M | 2016-04 |
